Leerink Partners Raises Price Target on Everyday Health (EVDY) to $27 Following 2Q15 EPS Beat

Leerink Partners reiterated an Outperform rating on Everyday Health (NYSE: EVDY), and raised the price target to $27.00 (from $26.00), following the company's 2Q15 results. EVDY reported 2Q15 revenue of $54.8m, in line with Street consensus. Non-GAAP EPS of $0.27, beat consensus by $0.14 due to a non-recurring tax benefit. Management lowered 2015 Guidance for adj. EBITDA by $3m, and reaffirmed revenue guidance for 2015 of $240m.

Analyst Steven Wardell commented, "Last night EVDY reported mostly in-line 2Q15 results and reiterated full year revenue guidance. The company also reported the acquisition of Tea Leaves Health, a health system CRM vendor, which should contribute to revenue starting in 2016."

For an analyst ratings summary and ratings history on Everyday Health click here. For more ratings news on Everyday Health click here.

Shares of Everyday Health closed at $11.73 yesterday.

You May Also Be Interested In

• UBS Upgrades UDR, Inc. (UDR) to Buy
• Mr. Cooper Group Inc. (COOP) PT Raised to $90 at Deutsche Bank
• Entergy Corp (ETR) PT Raised to $122 at Wells Fargo